Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX®) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective

Markov Models in Medical Decision Making

Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations

Engineering, Prognosis, Markov Decision Processes +21

6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE

Paul Abrams, Karl‐Erik Andersson, Apostolos Apostolidis et al. · Neurourology and Urodynamics · 2018 · 1.1K citations · Full text

Urology, Please Note, Voiding Dysfunction +12

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

Andrew Briggs, Milton C. Weinstein, Elisabeth Fenwick et al. · Value in Health · 2012 · 674 citations

Engineering, Uncertainty Quantification, Statistics +11

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

Francisco Cruz, Sender Herschorn, Philip J. Aliotta et al. · European Urology · 2011 · 467 citations

Urology, Voiding Dysfunction, Female Urology +6

Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity

David Ginsberg, Angelo E. Gousse, V. Keppenne et al. · The Journal of Urology · 2012 · 345 citations